Michelle Mackay - 23 Feb 2024 Form 4 Insider Report for Cushman & Wakefield plc (CWK)

Role
Chief Executive Officer, Director
Signature
/s/ Noelle J. Perkins, attorney-in-fact
Issuer symbol
CWK
Transactions as of
23 Feb 2024
Net transactions value
-$988,746
Form type
4
Filing time
27 Feb 2024, 16:36:39 UTC
Previous filing
05 Jul 2023
Next filing
16 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CWK Ordinary Shares Options Exercise $0 +37,992 +36% $0.000000 142,749 23 Feb 2024 Direct F1
transaction CWK Ordinary Shares Tax liability $206,956 -21,075 -15% $9.82 121,674 23 Feb 2024 Direct
transaction CWK Ordinary Shares Options Exercise $0 +22,643 +19% $0.000000 144,317 24 Feb 2024 Direct F1
transaction CWK Ordinary Shares Tax liability $122,966 -12,522 -8.7% $9.82 131,795 24 Feb 2024 Direct
transaction CWK Ordinary Shares Options Exercise $0 +33,682 +26% $0.000000 165,477 25 Feb 2024 Direct F1
transaction CWK Ordinary Shares Tax liability $182,917 -18,627 -11% $9.82 146,850 25 Feb 2024 Direct
transaction CWK Ordinary Shares Options Exercise $0 +87,635 +60% $0.000000 234,485 25 Feb 2024 Direct F2
transaction CWK Ordinary Shares Tax liability $475,907 -48,463 -21% $9.82 186,022 25 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CWK Restricted Stock Units Options Exercise $0 -37,992 -33% $0.000000 75,984 23 Feb 2024 Ordinary Shares 37,992 Direct F1, F3
transaction CWK Restricted Stock Units Options Exercise $0 -22,643 -50% $0.000000 22,643 24 Feb 2024 Ordinary Shares 22,643 Direct F1, F4
transaction CWK Restricted Stock Units Options Exercise $0 -33,682 -100% $0.000000* 0 25 Feb 2024 Ordinary Shares 33,682 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion of previously awarded restricted stock units ("RSUs") into an equal number of ordinary shares, without the payment of any consideration, pursuant to the Amended & Restated Cushman & Wakefield plc 2018 Omnibus Management Share and Cash Incentive Plan (the "A&R Omnibus Plan").
F2 Represents vesting of ordinary shares earned in respect of performance-based RSUs based on the achievement by the Issuer of certain performance targets for the 2021-2023 performance period pursuant to the A&R Omnibus Plan.
F3 RSUs were granted on February 23, 2023 and vest in three (3) equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.
F4 RSUs were granted on February 24, 2022 and vest in three (3) equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.
F5 RSUs were granted on February 25, 2021 and vest in three (3) substantially equal installments on each of the first three (3) anniversaries of the grant date, subject, with certain limited exceptions, to the reporting person's continuing employment through each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney